Skip to main content
OpenTrials

Clinical trial condition

Metastases

Explore clinical trials studying Metastases. Study availability and eligibility vary by location and protocol.

56 public trials 5 recruiting studies
Refine in advanced search Browse all conditions

Metastases trial results

Completed

Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer

NCT00083304

Conditions
Brain Diseases, Brain Neoplasms, Breast Cancer, +15 more
Locations
  • Virginia G. Piper Cancer Center, Arizona Oncology Services Phoenix, Arizona, United States
  • Arizona Cancer Center, University of Arizona Tucson, Arizona, United States
  • The University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
  • Alta Bates Comprehensive Cancer Center Berkeley, California, United States
View all 94 locations
View Trial Details
Completed

Iressa Expanded Access Program (EAP)

NCT00034879

Conditions
Bronchial Neoplasms, Carcinoma, Carcinoma, Bronchogenic, +17 more
Locations
  • Research Site Alabaster, Alabama, United States
  • Research Site Anniston, Alabama, United States
  • Research Site Birmingham, Alabama, United States
  • Research Site Gadsen, Alabama, United States
View all 626 locations
View Trial Details
Completed

MDX-010 Antibody, MDX-1379 Melanoma Vaccine, or MDX-010/MDX-1379 Combination Treatment for Patients With Unresectable or Metastatic Melanoma

NCT00094653

Conditions
Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations
  • Arizona Cancer Center Tucson, Arizona, United States
  • University Medical Center Tucson, Arizona, United States
  • City of Hope National Medical Center Duarte, California, United States
  • San Diego Cancer Center Encinitas, California, United States
View all 209 locations
View Trial Details
Completed

Erbitux (Cetuximab) Given Alone to Patients With EGFR-Negative Metastatic Colon or Rectal Cancer That is Refractory to Chemotherapy

NCT00083720

Conditions
Colonic Diseases, Colorectal Neoplasms, Digestive System Diseases, +14 more
Locations
  • ImClone Investigational Site Campbell, California, United States
  • ImClone Investigational Site Los Angeles, California, United States
  • ImClone Investigational Site Soquel, California, United States
  • ImClone Investigational Site Jacksonville, Florida, United States
View all 27 locations
View Trial Details
Completed

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

NCT00099970

Conditions
Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations
  • University of Alabama at Birmingham-Comprehensive Cancer Ctr. Birmingham, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • UCLA School of Medicine Los Angeles, California, United States
  • Cancer Institute Medical Group, Inc. Santa Monica, California, United States
View Trial Details

Related conditions